An important part of delivering a safe, successful patient experience starts with your securement solutions. The products your facility chooses, in addition to how clinicians apply and remove them, may seriously impact clinical outcomes, cost targets and patient care.
For every 100 patients who receive a medical tape application, 55 treatments for MARSI will be needed.1
Contamination was evident on 100% of 24 bedside tape rolls at 1, 5 and 7 days during a study conducted in a 16-bed ICU at a 560-bed teaching hospital.2
In one observation, 11 out of 21 tape samples used for multiple patients contained methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE).3
Our experts will conduct an audit of your current securement solutions mix, identify gaps and opportunities, align to your clinical needs and make recommendations to ensure you’re utilizing the right securement solutions for your facility’s priorities.
3M’s streamlined product portfolio, along with our in-depth training and education, makes it easy to choose the right securement product for the right patient and application, reducing confusion and the risk of complications like Medical Adhesive-Related Skin Injury (MARSI).
Keeping patients safe is everyone’s job. With our packaged single-patient-use products, we can help reduce the risk of cross-contamination caused by products used on multiple patients. And nearly all of our securement solutions are not made with natural latex rubber, helping protect patients with a latex sensitivity or allergy.
The right securement solutions can help reduce inventory costs and improve consistency of care, while making storage more efficient. Plus, with packaged single-patient-use rolls, you can reduce waste while you help reduce the risk of infection.
Protecting patient skin is everyone’s job, too. As a leader in adhesive science, 3M has securement solutions designed for every type of skin — from intact to at-risk — and we can help your facility implement skin-safe securement practices to help drive positive skin outcomes.
Our experts will work with your clinical champions to gather facility data that includes current securement product usage and applications, amount of securement waste, clinical demands and goals, and current purchasing process.
We’ll then evaluate the data, looking for inefficiencies we can turn into opportunities to improve everything from the ordering and inventory process to how clinicians select and apply each securement product.
Next, we’ll develop a recommendation for the right mix of securement products based on your facility’s needs, goals and compliance requirements. Plus, we’ll partner with you every step of the way to ensure the new plan is implemented successfully.
We’ll also follow up with training and additional resources to ensure your staff gets the information they need to make the right securement choice for the right clinical need.
Learn how to recognize the different types of MARSI, plus download our comprehensive guide to understanding and reducing the risk of MARSI.
1Maene, B. Hidden costs of medical tape-induced skin injuries. Wounds UK. 2013;9(1), 46-50.
2Berkowitz DM, Lee WS, Pazin GJ, Yee RB, Ho M. Adhesive tape: potential source of nosocomial bacteria. Appl Microbiol. 1974;28 (4):651–654.
3Harris PN, Ashhurst-Smith C, Berenger SJ, Shoobert A, Ferguson JK. Adhesive tape in the health care setting: another high-risk fomite? Med J Aust. 2012;196(1):34.